Ajit Ramalingam Bio Rad Laboratories, Inc. (BIO) insider trading activity

Ajit Ramalingam is SVP, Chief Accounting Officer of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 403 shares of BIO, which is worth approximately $131,434. The most recent transaction as insider was on Sep 02, 2023, when has been sold 84 shares (Bio-Rad A Common Stock) at a price of $394.6 per share, resulting in proceeds of $33,146. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 403

0% 3M change

0% 12M change

Total Value Held $131,434

AJIT RAMALINGAM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2023	SELL Payment of exercise price or tax liability	$33,146 $394.6 p/Share	84 Reduced 17.25%	403 Bio-Rad A Common Stock
Sep 02 2023	BUY Exercise of conversion of derivative security	-	241 Added 33.1%	487 Bio-Rad A Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$46,957 $394.6 p/Share	119 Reduced 32.6%	246 Bio-Rad A Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	342 Added 52.86%	305 Bio-Rad A Common Stock
Jun 06 2023	SELL Open market or private sale	$72,939 $368.38 p/Share	198 Reduced 100.0%	0 Bio-Rad A Common Stock
Apr 29 2023	SELL Payment of exercise price or tax liability	$43,275 $450.79 p/Share	96 Reduced 32.65%	198 Bio-Rad A Common Stock
Apr 29 2023	BUY Exercise of conversion of derivative security	-	277 Added 48.51%	294 Bio-Rad A Common Stock
Nov 10 2022	SELL Open market or private sale	$160,138 $422.53 p/Share	379 Reduced 100.0%	0 Bio-Rad A Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$40,179 $478.32 p/Share	84 Reduced 18.71%	365 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	241 Added 34.93%	449 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$28,689 $486.25 p/Share	59 Reduced 22.1%	208 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	169 Added 38.76%	267 Bio-Rad A Common Stock
Aug 05 2022	SELL Open market or private sale	$278,166 $537.0 p/Share	518 Reduced 84.09%	98 Bio-Rad A Common Stock
Apr 29 2022	SELL Payment of exercise price or tax liability	$49,158 $512.06 p/Share	96 Reduced 13.77%	601 Bio-Rad A Common Stock
Apr 29 2022	BUY Exercise of conversion of derivative security	-	277 Added 28.44%	697 Bio-Rad A Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$68,539 $825.77 p/Share	83 Reduced 17.55%	390 Bio-Rad A Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	-	240 Added 33.66%	473 Bio-Rad A Common Stock
Apr 29 2021	SELL Payment of exercise price or tax liability	$61,510 $640.73 p/Share	96 Reduced 30.28%	221 Bio-Rad A Common Stock
Apr 29 2021	BUY Exercise of conversion of derivative security	-	276 Added 46.54%	317 Bio-Rad A Common Stock

Ajit Ramalingam

SVP, Chief Accounting Officer

Hercules, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account